Effect of Unani Medicine Lauq-e-Khayarshambar in Nazla (Common Cold)

Clinical Validation of Unani Pharmacopoeal formulation Laooq Khayar Shambar in Nazla (Common Cold)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015445

Enrollment

240

Registered

2018-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system Health Condition 2: J459- Other and unspecified asthma

Interventions

Intervention1: Lauq-e-Khayarshambar: 10gm orally twice daily with lukewarm water for one week Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex in the age group of 18-65 2. Patients of Nazla (Common Cold) presenting with recent onset of any of the following symptoms: (i) KhushÅ«na al-Halaq (Sore Throat) (ii) Buhha al-Sawt Hoarseness / Change of Voice (iii)â??UtÄ?s â??Sneezing/ Nasal irritation (iv)Rhinorrhoea/Runny nose (v)SudÄ?â?? Headache (vi)Suâ??Ä?l Cough (vii)Iâ??yÄ? Malaise (viii)Low grade fever (100 - 101Â°F)

Exclusion criteria

Exclusion criteria: Any one of the following: 1. Patients of acute or chronic lower respiratory tract infection like pneumonia, Bronchitis, Asthma and Bronchiectasis. 2. High Grade Fever > 101oF 3. History of hepatic, renal disorders, diabetes mellitus, hypertension, anaemia, COPD or any other ailment requiring long term therapy 4. Known cases of any other acute illness 5. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Improvement in sign and symptoms of Nazla (Common Cold)Timepoint: Seven Days	—

Secondary

Measure	Time frame
Hematological and biochemical assessment for safetyTimepoint: Seven Days	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026